title: Pressure-reducing efficacy and tolerability of betaxolol in ionic solution.
authors.affiliation: Eye Clinic, University of Milan.
authors.forename: P
authors.initials: P
authors.lastname: Troiano
authors.forename: B
authors.initials: B
authors.lastname: Cavallotti
authors.forename: M
authors.initials: M
authors.lastname: Iraci
authors.forename: L
authors.initials: L
authors.lastname: Galli
authors.forename: M
authors.initials: M
authors.lastname: Miglior
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D000368:Aged; D015784:Betaxolol / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D005500:Follow-Up Studies; D005902:Glaucoma, Open-Angle / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D007429:Intraocular Pressure / Q000187:drug effects*; D008297:Male; D008875:Middle Aged; D009883:Ophthalmic Solutions; D012117:Resins, Synthetic; D012449:Safety; D016037:Single-Blind Method; D016896:Treatment Outcome
chemical_list: D000319:Adrenergic beta-Antagonists; D009883:Ophthalmic Solutions; D012117:Resins, Synthetic; C046797:amberlite; D015784:Betaxolol